JO
GH icon

John Overdeck’s Guardant Health GH Stock Holding History

John Overdeck’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558M Sell
3,719,301
-510,230
-12% -$55.5M 0.4% 39
2026
Q1 		$391M Buy
4,229,531
+2,057,628
+95% +$207M 0.32% 56
2025
Q4 		$222M Buy
2,171,903
+368,572
+20% +$33M 0.31% 49
2025
Q3 		$113M Sell
1,803,331
-51,280
-3% -$2.79M 0.17% 164
2025
Q2 		$96.5M Buy
1,854,611
+28,748
+2% +$1.28M 0.17% 163
2025
Q1 		$77.8M Sell
1,825,863
-64,851
-3% -$2.8M 0.17% 151
2024
Q4 		$57.8M Buy
1,890,714
+525,368
+38% +$14.8M 0.13% 201
2024
Q3 		$31.3M Buy
1,365,346
+550,823
+68% +$15.6M 0.07% 354
2024
Q2 		$23.5M Buy
814,523
+563,595
+225% +$13.1M 0.05% 409
2024
Q1 		$5.18M Sell
250,928
-333,629
-57% -$7.15M 0.01% 948
2023
Q4 		$15.8M Sell
584,557
-517,316
-47% -$13.6M 0.04% 496
2023
Q3 		$32.7M Buy
1,101,873
+83,825
+8% +$2.95M 0.09% 270
2023
Q2 		$36.4M Buy
1,018,048
+231,591
+29% +$6.65M 0.09% 269
2023
Q1 		$18.4M Buy
786,457
+299,037
+61% +$8.54M 0.05% 397
2022
Q4 		$13.3M Buy
487,420
+307,821
+171% +$14.1M 0.04% 467
2022
Q3 		$9.67M Sell
179,599
-52,217
-23% -$2.68M 0.03% 500
2022
Q2 		$9.35M Buy
+231,816
New +$11.5M 0.03% 541
2021
Q4 		– Sell
-2,200
Closed -$228K – 4492
2021
Q3 		$275K Sell
2,200
-140,281
-98% -$16.7M ﹤0.01% 3736
2021
Q2 		$17.7M Buy
142,481
+21,525
+18% +$2.9M 0.04% 537
2021
Q1 		$18.5M Buy
120,956
+118,200
+4,289% +$17.9M 0.05% 470
2020
Q4 		$355K Buy
+2,756
New +$317K ﹤0.01% 2740
2019
Q4 		– Sell
-34,332
Closed -$2.47M – 3760
2019
Q3 		$2.19M Buy
+34,332
New +$3.02M 0.01% 1361

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

John Overdeck's GH Position: Q2 2026 in Review

John Overdeck reduced its Guardant Health (GH) stake by 12% in Q2 2026, selling an estimated $55.5M and leaving 3,719,301 shares worth $558M. The position accounts for 0.4% of the portfolio, ranked #39.

John Overdeck first reported a position in GH in Q3 2019 and has held it in 22 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • John Overdeck held 3,719,301 shares of Guardant Health worth $558M as of Q2 2026.
  • John Overdeck sold 510,230 Guardant Health shares in Q2 2026, an estimated $55.5M.
  • Guardant Health made up 0.4% of John Overdeck's portfolio in Q2 2026, its #39 holding.
  • John Overdeck first reported a position in Guardant Health in Q3 2019 and has held it in 22 quarters since.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.